Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $998.44 | 20 | 98.4% |
| Education | $16.25 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $430.70 | 5 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $168.58 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $142.74 | 2 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $117.75 | 5 | $0 (2023) |
| PFIZER PHARMACEUTICALS LLC | $101.33 | 1 | $0 (2018) |
| Medtronic, Inc. | $28.59 | 1 | $0 (2024) |
| PBG PUERTO RICO LLC | $25.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53.59 | 2 | Medtronic, Inc. ($28.59) |
| 2023 | $261.27 | 6 | AstraZeneca Pharmaceuticals LP ($124.99) |
| 2022 | $93.15 | 4 | E.R. Squibb & Sons, L.L.C. ($42.55) |
| 2021 | $42.75 | 2 | PBG PUERTO RICO LLC ($25.00) |
| 2019 | $28.00 | 1 | Janssen Pharmaceuticals, Inc ($28.00) |
| 2018 | $482.58 | 3 | E.R. Squibb & Sons, L.L.C. ($365.00) |
| 2017 | $53.35 | 3 | Janssen Pharmaceuticals, Inc ($30.20) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 06/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: DIABETES | ||||||
| 12/06/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.37 | General |
| Category: DIABETES | ||||||
| 08/31/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: DIABETES | ||||||
| 08/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: DIABETES | ||||||
| 03/10/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: DIABETES | ||||||
| 03/01/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/02/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.80 | General |
| Category: Cardiovascular | ||||||
| 07/05/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: DIABETES | ||||||
| 06/28/2022 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/31/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.75 | General |
| Category: Cardiovascular | ||||||
| 12/09/2021 | PBG PUERTO RICO LLC | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/09/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/13/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/15/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $365.00 | General |
| 03/22/2018 | PFIZER PHARMACEUTICALS LLC | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $101.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/15/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $16.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/07/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.00 | General |
| Category: Cardiovascular | ||||||
| 07/15/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/01/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.15 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 29 | 38 | $2,075 | $1,393 |
| 2022 | 2 | 33 | 42 | $2,246 | $1,528 |
| 2021 | 2 | 44 | 67 | $3,982 | $2,372 |
| 2020 | 2 | 42 | 63 | $2,867 | $1,693 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 20 | $1,814 | $1,211 | 66.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 18 | $261.09 | $182.23 | 69.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 21 | $1,939 | $1,309 | 67.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 18 | 21 | $306.39 | $218.49 | 71.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 38 | $3,547 | $2,084 | 58.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 21 | 29 | $435.30 | $288.05 | 66.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 30 | $2,293 | $1,343 | 58.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 25 | 33 | $574.20 | $350.19 | 61.0% |
About Dr. Olga Pacheco, MD
Dr. Olga Pacheco, MD is a Cardiovascular Disease healthcare provider based in Bayamon, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821175605.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Olga Pacheco, MD has received a total of $1,015 in payments from pharmaceutical and medical device companies, with $53.59 received in 2024. These payments were reported across 21 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($998.44).
As a Medicare-enrolled provider, Pacheco has provided services to 148 Medicare beneficiaries, totaling 210 services with total Medicare billing of $6,985. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Bayamon, PR
- Active Since 11/01/2006
- Last Updated 11/09/2012
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1821175605
Products in Payments
- ELIQUIS (Drug) $170.23
- JARDIANCE (Drug) $168.58
- FARXIGA (Drug) $124.99
- XARELTO (Drug) $96.32
- LINQ II (Device) $28.59
- CAMZYOS (Drug) $21.80
- INVOKANA (Drug) $21.43
- BRILINTA (Drug) $17.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Bayamon
Dr. Jose Novoa, M.d, M.D
Cardiovascular Disease — Payments: $412,359
Juan Igartua Ponton, M.d.f.a.c.c, M.D.F.A.C.C
Cardiovascular Disease — Payments: $58,670
Dr. Luis Molinary Fernandez, M.d, M.D
Cardiovascular Disease — Payments: $36,956
Dr. Domingo Perez, Md, MD
Cardiovascular Disease — Payments: $9,863
Jose Rodriguez Castro, Md, MD
Cardiovascular Disease — Payments: $4,818
Mr. Edwin Alejandro, Md, MD
Cardiovascular Disease — Payments: $4,567